Disease | Common pathogen | Symptoms | Transmission | Diagnostic tests | Treatment |
---|---|---|---|---|---|
Bacterial keratitis | CoNS Staphylococcus aureus Streptococcus pneumoniae Pseudomonasaeruginosa | Blurred vision, redness, photophobia. | Exposure to pathogens CL wear Ocular surface disease Ocular trauma Topical steroid use Previous microbial keratitis | Gram staining Sensitivity: 60-75% Culture Sensitivity: 38-66% PCR Sensitivity: 25-88% | Broad-spectrum topical antibiotics15 Monotherapy with fluoroquinolone OR Fortified antibiotics: Cephazolin 5% plus gentamicin 0.9% Consider adjuvant topical steroid at least 2–3 days of improvement when Organism has been identified and corneal infiltrate compromises the visual axis |
Herpes simplex keratitis | Herpes simplex virus type 1 | redness, discharge, watery eyes, irritations, itching, pain and photophobia | Direct contact with infected lesions or their secretions. | PCR Sensitivity: 70-100% Specificity: 67.9-98% | Australian HSK recommendations16 Occ ACV 3% five times daily for 1–2 weeks OR VLC 500 mg BD, 7 daysb VLC 500 mg once daily during topical steroid use PLUS Prednefrin Forte 4–6 times daily tapered over > 10 weeks |
Fungal keratitis | Fusarium spp. and Aspergillus spp Candida spp | Redness, tearing, pain, sensitivity to light, discharge, decreased vision | Corneal injury Contact lens wear Ocular surface disease conditions: dry eye, blepharitis, bullous ke | Gram and Giemsa Sensitivity: 65-75% 10% KOH Sensitivity: 61-99.23% Specificity: 91-97%. Culture: Blood and chocolate and Sabouraud dextrose agar PCR Sensitivity: 75-100% Specificity: 50-100% IVCM Sensitivity: 80-94% Specificity: 78-91.1%. | Topical natamycin 5% Topical voriconazole 1% Amphotericin B 0.15% |